During the past decade, Instituto de Ensino e Pesquisa Clinica do Ceara conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Ensino e Pesquisa Clinica do Ceara" are "Diabetes Mellitus, Type 2" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Instituto de Ensino e Pesquisa Clinica do Ceara" in a lesser frequency.

Most popular intervention types in "Instituto de Ensino e Pesquisa Clinica do Ceara" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Cobimetinib" (1 trials), "Metformin DR" (1 trials) and "Metformin DR Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Ensino e Pesquisa Clinica do Ceara" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Ensino e Pesquisa Clinica do Ceara". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto de Ensino e Pesquisa Clinica do Ceara, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Ensino e Pesquisa Clinica do Ceara, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".